These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 833544)

  • 21. Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
    Zou R; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):811-8. PubMed ID: 9057868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the enhancement of interferon production in human diploid (FS-4) cells by ultraviolet.
    Kohase M; Vilcek J
    Jpn J Med Sci Biol; 1978 Feb; 31(1):17-26. PubMed ID: 661008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Balbiani ring RNA synthesis at the initiation level.
    Egyházi E
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):947-50. PubMed ID: 1055392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antiviral activity of certain 5'-modified analogs of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
    Gudmundsson KS; Drach JC; Wotring LL; Townsend LB
    J Med Chem; 1997 Feb; 40(5):785-93. PubMed ID: 9057865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of HeLa-S3 cell proliferation and biosynthesis by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).
    Tamm I; Kikuchi T
    Proc Soc Exp Biol Med; 1983 Jun; 173(2):238-43. PubMed ID: 6191332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature.
    Vilcek J; Havell EA
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3909-13. PubMed ID: 4544057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between structure of benzimidazole derivatives and selective virus inhibitory activity. Inhibition of poliovirus multiplication and cytopathic effects by 2-(alpha-hydroxybenzyl)-benzimidazole, and its 5-chloroderivative.
    TAMM I; BABLANIAN R; NEMES MM; SHUNK CH; ROBINSON FM; FOLKERS K
    J Exp Med; 1961 Apr; 113(4):625-56. PubMed ID: 13775109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.
    Evers DL; Komazin G; Ptak RG; Shin D; Emmer BT; Townsend LB; Drach JC
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3918-27. PubMed ID: 15388453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dynamics of production and the sensitivity to cycloheximide and actinomycin D of interferon-inducing and interferon messenger RNA.
    Orlova TG; Kognovitskaya AI; Georgadze II; Solovyov VD
    Acta Virol; 1976 Feb; 20(1):9-14. PubMed ID: 7951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery of HeLa cell population growth after treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).
    Tamm I
    J Cell Physiol; 1983 Jul; 116(1):26-34. PubMed ID: 6853610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and antiviral evaluation of 2-deoxy-D-ribosides of substituted benzimidazoles as potential agents for human cytomegalovirus infections.
    Zou R; Kawashima E; Freeman GA; Koszalka GW; Drach JC; Townsend LB
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):125-53. PubMed ID: 10772706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5,6-Dichloro-1-Beta-D-ribofuranosylbenzimidazole inhibits initiation of nuclear heterogeneous RNA chains in HeLa cells.
    Sehgal PB; Derman E; Molloy GR; Tamm I; Darnell JE
    Science; 1976 Oct; 194(4263):431-3. PubMed ID: 982026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of influenza virus multiplication by N-glycosides of benzimidazoles-N.
    TAMM I; FOLKERS K; SHUNK CH; HORSFALL FL
    J Exp Med; 1954 Mar; 99(3):227-50. PubMed ID: 13130796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of messenger RNA synthesis by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole without its detectable accumulation in mouse T-lymphoma cells.
    Tweeten KA; Molloy GR
    Arch Biochem Biophys; 1982 Aug; 217(1):332-40. PubMed ID: 6181742
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulse and steady-state labelled and actinomycin D chased 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)-resistant hnRNA from uninfected HeLa cells.
    Brysch B
    Acta Biochim Pol; 1983; 30(3-4):311-24. PubMed ID: 6201028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definition of subclasses of nucleoplasmic RNA.
    Tamm I
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):5011-5. PubMed ID: 270736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HeLa cell RNA and protein syntheses. Effects of long-term treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).
    Tamm I
    Biochem Pharmacol; 1984 Feb; 33(4):551-7. PubMed ID: 6200120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A DRB (5,6 dichloro-beta-D-ribofuranosylbenzimidazole)-resistant adenovirus mRNA.
    Vennström B; Persson H; Pettersson U; Philipson L
    Nucleic Acids Res; 1979 Nov; 7(6):1405-18. PubMed ID: 503856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of 2-mercapto-1(beta-4-pyridethyl)benzimidazole: a reversible inhibitor of interferon activity.
    Friedman RM; Pastan I
    Proc Natl Acad Sci U S A; 1970 Jan; 65(1):104-9. PubMed ID: 4313191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between interferon production and interferon messenger RNA synthesis in human fibroblasts.
    Raj NB; Pitha PM
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1483-7. PubMed ID: 266188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.